Cystic fibrosis mice lacking Muc1 have reduced amounts of intestinal mucus.

Por Parmley, R R, Gendler, S J
Publicado em 1998

MUC1 alters oncogenic events and transcription in human breast cancer cells

Por Hattrup, Christine L, Gendler, Sandra J
Publicado em 2006

Designer Glycopeptides for Cytotoxic T Cell–based Elimination of Carcinomas

Por Xu, Yanfei, Gendler, Sandra J., Franco, Alessandra
Publicado em 2004

Expression of Human MUC1 During Early Pregnancy in the Human MUC1 Transgenic Mouse Model

Por Dharmaraj, Neeraja, Gendler, Sandra J., Carson, Daniel D.
Publicado em 2009

Lack of Muc1-regulated beta-catenin stability results in aberrant expansion of CD11b(+)Gr1(+) myeloid derived suppressor cells from the bone marrow

Por Poh, Tze Wei, Bradley, Judy M., Mukherjee, Pinku, Gendler, Sandra J.
Publicado em 2009

Human Breast Cancer Stem Cells Have Significantly Higher Rate of Clathrin-Independent and Caveolin-Independent Endocytosis than the Differentiated Breast Cancer Cells

Por Palaniyandi, Kanagaraj, Pockaj, Barbara A., Gendler, Sandra J., Chang, Xiu-Bao
Publicado em 2012

Inhibition of adaptive immunity by IL-9 can be disrupted to achieve rapid T cell sensitization and rejection of progressive tumor challenges

Por Hoelzinger, Dominique B., Dominguez, Ana Lucia, Cohen, Peter A., Gendler, Sandra J.
Publicado no Cancer Res (2014)

Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells

Por Basu, Gargi D, Pathangey, Latha B, Tinder, Teresa L, Gendler, Sandra J, Mukherjee, Pinku
Publicado em 2005

Cloning of partial cDNA encoding differentiation and tumor-associated mucin glycoproteins expressed by human mammary epithelium.

Por Gendler, S J, Burchell, J M, Duhig, T, Lamport, D, White, R, Parker, M, Taylor-Papadimitriou, J
Publicado em 1987

MUC1 Mucin Is a Negative Regulator of Toll-Like Receptor Signaling

Por Ueno, Keiko, Koga, Takeshi, Kato, Kosuke, Golenbock, Douglas T., Gendler, Sandra J., Kai, Hirofumi, Kim, K. Chul
Publicado em 2008

Selection and characterization of MUC1-specific CD8(+) T cells from MUC1 transgenic mice immunized with dendritic-carcinoma fusion cells

Por Gong, J, Apostolopoulos, V, Chen, D, Chen, H, Koido, S, Gendler, S J, Mckenzie, I F, Kufe, D
Publicado em 2000

Aberrant Glycosylation of Anchor-Optimized MUC1 Peptides Can Enhance Antigen Binding Affinity and Reverse Tolerance to Cytotoxic T Lymphocytes

Por Pathangey, Latha B., Lakshminarayanan, Vani, Suman, Vera J., Pockaj, Barbara A., Mukherjee, Pinku, Gendler, Sandra J.
Publicado no Biomolecules (2016)

Modification of the Tumor Microenvironment as a Novel Target of Renal Cell Carcinoma Therapeutics

Por Finke, James H, Rayman, Pat A, Ko, Jennifer S, Bradley, Judy M., Gendler, Sandra J, Cohen, Peter A
Publicado em 2013

MUC1-specific immune therapy generates a strong anti-tumor response in a MUC1-tolerant colon cancer model

Por Mukherjee, P., Pathangey, L.B., Bradley, J.B., Tinder, T.L., Basu, G.D., Akporiaye, E.T., Gendler, S.J.
Publicado em 2006

Importance and regulation of the colonic mucus barrier in a mouse model of colitis

Por Petersson, J., Schreiber, O., Hansson, G. C., Gendler, S. J., Velcich, A., Lundberg, J. O., Roos, S., Holm, L., Phillipson, M.
Publicado em 2011

Targeted imaging of breast tumor progression and therapeutic response in a human uMUC-1 expressing transgenic mouse model

Por Ghosh, Subrata K., Uchida, Masashi, Yoo, Byunghee, Ross, Alana W., Gendler, Sandra J., Gong, Jianlin, Moore, Anna, Medarova, Zdravka
Publicado em 2012

The MUC1 Cytoplasmic Tail and Tandem Repeat Domains Contribute to Mammary Oncogenesis in FVB Mice

Por Hattrup, Christine L., Bradley, Judy M., Kotlarczyk, Kari L., Madsen, Cathy S., Hentz, Joseph G., Marler, Ronald J., Gendler, Sandra J.
Publicado em 2008

Core-glycosylated Mucin-like Repeats from MUC1 Are an Apical Targeting Signal

Por Kinlough, Carol L., Poland, Paul A., Gendler, Sandra J., Mattila, Polly E., Mo, Di, Weisz, Ora A., Hughey, Rebecca P.
Publicado em 2011

Down regulation of hematopoietic MUC1 during experimental colitis increases tumor promoting myeloid-derived suppressor cells

Por Poh, Tze Wei, Madsen, Cathy S., Gorman, Jessica E., Marler, Ronald J., Leighton, Jonathan A., Cohen, Peter A., Gendler, Sandra J.
Publicado em 2013

Intratumoral delivery of CpG-conjugated anti-MUC1 antibody enhances NK cell anti-tumor activity

Por Schettini, Jorge, Kidiyoor, Amritha, Besmer, Dahlia M., Tinder, Teresa L., Roy, Lopamudra Das, Lustgarten, Joseph, Gendler, Sandra J., Mukherjee, Pinku
Publicado em 2012